Program

1
1

Journal Year Published

1
1

Author

2
182
174
134
134
125
118
116
114
108
88
86
81
73
56
51
50
43
43
42
34

Category

2
1
1

Keyword

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

Journal

1
1

NCATS Publications

RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of topoisomerase inhibitors.


Martin SE, Wu ZH, Gehlhaus K, Jones R, Zhang YW, Guha R, Miyamoto S, Pommier Y, Caplen NJ


Curr Cancer Drug Targets , (11), 976-86, 2011.

Pubmed

Sample image from publication page